Ferritin Testing Market Supported by Increasing Preventive Healthcare

The global ferritin testing market size was estimated at USD 907.67 million in 2024 and is projected to reach USD 1.46 billion by 2030, expanding at a CAGR of 8.0% from 2025 to 2030. Growth is primarily driven by the rising prevalence of iron deficiency anemia and iron overload disorders such as hemochromatosis, which has significantly increased the need for accurate and accessible ferritin testing solutions.

Key Market Trends & Insights

• The North America dominated the market with a share of 36.65% in 2024.
• The ferritin testing market in the U.S. is experiencing robust growth.
• Based on product, the reagent segment held the largest share of 45.27% in 2024.
• Based on application, the anemia segment held the largest share of 41.47% in 2024.
• Based on end-use, the hospitals segment held the largest market share of 56.32% in 2024 and is also expected to grow at the fastest CAGR of 8.14% over the forecast period from 2025 to 2030.

Market Size & Forecast

• 2024 Market Size: USD 907.67 Million
• 2030 Projected Market Size: USD 1.46 Billion
• CAGR (2025-2030): 8.0%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

North America led the market with a 36.65% share in 2024, supported by well-established diagnostic infrastructure and high disease awareness. The U.S. market demonstrated strong adoption of both laboratory-based and point-of-care diagnostic tools. Based on product segmentation, reagents accounted for the largest share of 45.27% in 2024. Anemia remained the dominant application segment with a 41.47% share. Hospitals represented the largest end-use segment at 56.32% in 2024 and are projected to maintain the fastest growth trajectory, with a CAGR of 8.14% from 2025 to 2030.

Increasing awareness of the importance of iron monitoring in maternal health, chronic diseases, and pediatric populations continues to elevate demand. Technological innovations, including automated analyzers, portable diagnostics, and advanced point-of-care ferritin test kits, have improved accuracy, accessibility, and turnaround time. Expanding healthcare infrastructure, particularly in Asia Pacific, supports early detection and effective management of iron-related disorders.

Recent technological breakthroughs have reshaped ferritin testing through the introduction of microfluidic paper analytical devices (µPADs) and paper-based electrochemical immunosensors. These innovations provide cost-effective, portable, and rapid testing capabilities, especially valuable for low-resource regions. Solutions like µPADs enable ferritin measurement using capillary whole blood, increasing availability in remote settings. Systems such as QDx Instacheck further strengthen the shift toward decentralized diagnostics.

Maternal and child health remains a crucial area of application. Iron deficiency anemia poses significant risks during pregnancy and early childhood, making early ferritin screening essential. Portable testing devices allow integration of ferritin assessment into routine antenatal and pediatric care, improving outcomes in underserved communities through timely intervention.

Ferritin testing also serves an essential role in managing chronic conditions linked to iron overload, including hemochromatosis, liver disease, and chronic kidney disease. Automated immunoassay platforms and next-generation analyzers deliver enhanced precision. The adoption of AI and machine learning is expected to further transform ferritin-based diagnostics by enabling multi-biomarker analysis and personalized iron-status evaluation.

Growing consumer interest in preventive healthcare has expanded opportunities for home-based ferritin testing solutions. Capillary blood kits integrated with smartphone applications are gaining traction, offering individuals a convenient way to monitor iron levels and address deficiencies before the onset of clinical symptoms.

Order a free sample PDF of the Ferritin Testing Market Intelligence Study, published by Grand View Research.

Key Company Insights

Leading players in the market continue to adopt strategies such as product innovation, partnerships, and geographic expansion to strengthen their competitive position. Prominent companies include:

• Eurolyser Diagnostica GmbH
• Cortez Diagnostics Inc
• Pointe Scientific, Inc
• bioMérieux
• Humankind Ventures Ltd
• Aviva Systems Biology Corporation
• Abnova Corporation
• Cosmic Scientific Technologies
• CTK Biotech, Inc
• Thermo Fisher Scientific Inc.

Conclusion

The ferritin testing market is experiencing sustained growth fueled by rising global awareness of iron-related disorders, advances in diagnostic technologies, and increasing emphasis on preventive healthcare. The expanding availability of point-of-care and home-based testing devices is reshaping access to ferritin diagnostics, particularly in emerging economies. Strong participation from leading diagnostic manufacturers and growing integration of AI-enhanced platforms will continue to elevate accuracy, accessibility, and clinical decision-making.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.